This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nicolas Preitner: Innovator in Neurological Treatments
Introduction
Nicolas Preitner is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of neurological health through his innovative research and patenting efforts. His work focuses on the prevention and treatment of neurological diseases and conditions.
Latest Patents
Nicolas Preitner holds a patent for "Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions." This invention provides compositions that include at least one N-acetyl cysteine and at least one nicotinamide riboside. These compositions are designed for use in methods aimed at preventing and treating neurological diseases and conditions. The invention emphasizes maintaining or improving brain function, particularly addressing brain energy deficits. Additionally, it aims to enhance neurological recovery and regeneration following injury or surgery.
Career Highlights
Nicolas Preitner is associated with Société des Produits Nestlé S.A., where he applies his expertise in developing innovative solutions for neurological health. His work has garnered attention for its potential impact on improving brain function and recovery processes.
Collaborations
Nicolas collaborates with talented individuals such as Laura Trovo and Bernard Cuenoud, contributing to a dynamic research environment focused on advancing neurological treatments.
Conclusion
Nicolas Preitner's innovative work in the field of neurological health showcases his commitment to improving patient outcomes through scientific advancements. His patent reflects a significant step forward in the prevention and treatment of neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
